Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “B-cell Malignancies”
Approved 1
- ZanubrutinibBeOne Medicines Ltd.B-cell Malignancies
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.